# Gold Royalty Corp.: overview

GROY · NYSE · CIK 1834026 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/groy.md) · [Financials](/companies/groy/financials.md) · [Filings](/companies/groy/filings.md) · [Insiders](/companies/groy/insiders.md)

Latest reported revenue: [$582.0k](/filings/0000950170-25-042306.md) for Q1 FY2023, three months to 2022-12-31, from the 20-F filed Mar 20, 2025 (XBRL ifrs-full:Revenue, accession 0000950170-25-042306).

## Last eight quarters

| Line item | Unit | period not labelled (2020-09-30) | Q1 FY2023 (2022-12-31) |
| --- | --- | ---: | ---: |
| Revenue | $k | not reported | [582](/filings/0000950170-25-042306.md) |
| Gross margin | % | not reported | [62.9%](/filings/0000950170-25-042306.md) |
| Operating margin | % | not reported | [(632.3%)](/filings/0000950170-25-042306.md) |
| Net margin | % | not reported | [(378.7%)](/filings/0000950170-25-042306.md) |
| Diluted EPS | $ per share | not reported | [(0.02)](/filings/0000950170-25-042306.md) |
| Free cash flow | $k | not reported | not reported |

- Revenue. XBRL Revenue: ifrs-full:Revenue.
- Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:Revenue.
- Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:Revenue.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:Revenue.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-09-30) | FY2022 (2022-09-30) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.2](/filings/0000950170-24-037537.md) | [3.9](/filings/0000950170-25-042306.md) | [3.0](/filings/0001193125-26-114767.md) | [10.1](/filings/0001193125-26-114767.md) | [15.6](/filings/0001193125-26-114767.md) |
| Gross margin | % | [14.6%](/filings/0000950170-24-037537.md) | [55.5%](/filings/0000950170-25-042306.md) | [69.1%](/filings/0001193125-26-114767.md) | [65.6%](/filings/0001193125-26-114767.md) | [76.4%](/filings/0001193125-26-114767.md) |
| Operating margin | % | [(6552.6%)](/filings/0000950170-24-037537.md) | [(544.0%)](/filings/0000950170-25-042306.md) | [(1016.1%)](/filings/0001193125-26-114767.md) | [(40.2%)](/filings/0001193125-26-114767.md) | [9.9%](/filings/0001193125-26-114767.md) |
| Net margin | % | [(7815.6%)](/filings/0000950170-24-037537.md) | [(439.8%)](/filings/0000950170-25-042306.md) | [(877.8%)](/filings/0001193125-26-114767.md) | [(33.8%)](/filings/0001193125-26-114767.md) | [(26.5%)](/filings/0001193125-26-114767.md) |
| Diluted EPS | $ per share | [(0.45)](/filings/0000950170-24-037537.md) | [(0.14)](/filings/0000950170-25-042306.md) | [(0.18)](/filings/0001193125-26-114767.md) | [(0.02)](/filings/0001193125-26-114767.md) | [(0.02)](/filings/0001193125-26-114767.md) |
| Free cash flow | $m | [(12.0)](/filings/0000950170-24-037537.md) | [(19.3)](/filings/0000950170-25-042306.md) | not reported | not reported | not reported |

- Revenue. XBRL Revenue: ifrs-full:Revenue.
- Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:Revenue.
- Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:Revenue.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:Revenue.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/groy/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $18.5m | 6,689,585 |  | Added +966,207 |
| [Regal Partners Ltd](/funds/1577774.md) | 2026-06-30 | $15.8m | 5,712,223 |  | Unchanged |
| [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $14.7m | 5,334,227 |  | Reduced −23,122 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $14.3m | 5,197,213 |  | Added +539,707 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $13.1m | 4,742,223 |  | Reduced −1,216,912 |
| [Amundi](/funds/1330387.md) | 2026-06-30 | $9.7m | 3,500,000 |  | Added +500,000 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $7.7m | 2,791,973 |  | Added +775,148 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $6.4m | 2,311,195 |  | Reduced −1,652,300 |
| [BANK OF MONTREAL /CAN/](/funds/927971.md) | 2026-06-30 | $6.0m | 2,159,337 |  | Added +226,934 |
| [Groupe la Francaise](/funds/2056088.md) | 2026-06-30 | $5.0m | 1,800,000 |  | Added +100,000 |

## Recent filings

[All 304 filings](/companies/groy/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 21:10 ET | [6-K](/filings/0001493152-26-046364.md) | Report of a foreign private issuer, period 2026-10-08 | 0001493152-26-046364 |
| 2026-08-05 | 20:49 ET | [6-K](/filings/0001193125-26-335353.md) | Report of a foreign private issuer, period 2026-08-05 | 0001193125-26-335353 |
| 2026-08-05 | 20:47 ET | [6-K](/filings/0001493152-26-036199.md) | Report of a foreign private issuer, period 2026-08-05 | 0001493152-26-036199 |
| 2026-07-30 | 22:01 ET | [SCHEDULE 13D/A](/filings/0001104659-26-088829.md) | Ownership report, active investor, amended | 0001104659-26-088829 |
| 2026-07-13 | 21:12 ET | [6-K](/filings/0001493152-26-033077.md) | Report of a foreign private issuer, period 2026-07-13 | 0001493152-26-033077 |
| 2026-06-15 | 21:12 ET | [6-K](/filings/0001493152-26-028721.md) | Report of a foreign private issuer, period 2026-06-15 | 0001493152-26-028721 |
| 2026-05-08 | 23:14 ET | [6-K](/filings/0001493152-26-021804.md) | Report of a foreign private issuer, period 2026-05-07 | 0001493152-26-021804 |
| 2026-05-07 | 01:01 ET | [6-K](/filings/0001493152-26-021574.md) | Report of a foreign private issuer, period 2026-05-06 | 0001493152-26-021574 |
| 2026-05-07 | 00:52 ET | [6-K](/filings/0001193125-26-209815.md) | Report of a foreign private issuer, period 2026-05-06 | 0001193125-26-209815 |
| 2026-04-27 | 10:40 ET | [6-K](/filings/0001493152-26-019031.md) | Report of a foreign private issuer, period 2026-04-27 | 0001493152-26-019031 |

## Latest annual report

[Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-114767.md), filed Mar 19, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1834026
- Tickers: GROY, GROY-WT
- Exchange: NYSE
- SIC code: 1040 Gold and Silver Ores
- State of incorporation: Z4
- Filer category: Non-accelerated filer<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.
